Review of Safe Valproate Prescribing in Female of Childbearing Age and Male of Reproductive Potential
By Mazeda Khanam, pharmacist, National Hospital of Neurology and Neurosurgery
Project poster
Project write up
More Neuropharmacy Academy Medication Projects
Reviewing monitoring requirements for disease-modifying therapies (DMTs) used in Multiple Sclerosis (MS) within a tertiary neurology centre: A Cost Improvement Project
By Tyler Allen, pharmacist & Emma Stephenson, advanced clinical pharmacist in neurology and MS, South Tees Hospitals NHS Foundation Trust
Review of Safe Valproate Prescribing in Female of Childbearing Age and Male of Reproductive Potential
By Mazeda Khanam, pharmacist, National Hospital of Neurology and Neurosurgery
Natalizumab Biosimilar Switch Tysabri® to Tyruko® Across Two District General Hospitals
By Rebecca Harrison, lead pharmacist, Royal United Hospitals, Bath
Developing neuropharmacists, supporting collaborative care
Knowledgeable pharmacists can initiate or support new treatment pathways, play an important role in patient education, medicine adherence, efficacy and safety, and provide advice to other healthcare professionals involved in the person's care. This Academy recognises the value of this essential role, and seeks to enhance pharmacist's clinical skills and build their confidence in managing a range of neurological conditions.